ZA86813B - Basic compounds - Google Patents
Basic compoundsInfo
- Publication number
- ZA86813B ZA86813B ZA86813A ZA86813A ZA86813B ZA 86813 B ZA86813 B ZA 86813B ZA 86813 A ZA86813 A ZA 86813A ZA 86813 A ZA86813 A ZA 86813A ZA 86813 B ZA86813 B ZA 86813B
- Authority
- ZA
- South Africa
- Prior art keywords
- basic compounds
- compounds
- basic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858503427A GB8503427D0 (en) | 1985-02-11 | 1985-02-11 | Basic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA86813B true ZA86813B (en) | 1986-11-26 |
Family
ID=10574272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA86813A ZA86813B (en) | 1985-02-11 | 1986-02-04 | Basic compounds |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0194047A1 (hu) |
JP (1) | JPS61233666A (hu) |
AU (1) | AU5326586A (hu) |
DK (1) | DK65586A (hu) |
ES (1) | ES8802029A1 (hu) |
FI (1) | FI860617A (hu) |
GB (1) | GB8503427D0 (hu) |
GR (1) | GR860365B (hu) |
HU (1) | HUT40411A (hu) |
IE (1) | IE860267L (hu) |
IL (1) | IL77800A0 (hu) |
NO (1) | NO860461L (hu) |
PT (1) | PT82006B (hu) |
ZA (1) | ZA86813B (hu) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4868181A (en) * | 1986-08-04 | 1989-09-19 | E. I. Du Pont De Nemours And Company | 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity |
US4782160A (en) * | 1986-12-08 | 1988-11-01 | Yamanouchi Pharmaceutical Co., Ltd. | 1,4-dihydropyridine derivatives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2228363A1 (de) * | 1972-06-10 | 1974-01-03 | Bayer Ag | 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
GB1409865A (en) * | 1973-02-13 | 1975-10-15 | Science Union & Cie | Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them |
US4500527A (en) * | 1983-06-22 | 1985-02-19 | Usv Pharmaceutical Corporation | Antihypertensive 4[(3-alkylamino-2-hydroxypropyl)-oxyiminomethyl phenyl]-1,4-dihydropyridines |
JPS6112662A (ja) * | 1984-06-28 | 1986-01-21 | Yamanouchi Pharmaceut Co Ltd | ジヒドロピリジン誘導体及びその製法 |
-
1985
- 1985-02-11 GB GB858503427A patent/GB8503427D0/en active Pending
-
1986
- 1986-01-30 IE IE860267A patent/IE860267L/xx unknown
- 1986-02-04 ZA ZA86813A patent/ZA86813B/xx unknown
- 1986-02-05 IL IL77800A patent/IL77800A0/xx unknown
- 1986-02-06 AU AU53265/86A patent/AU5326586A/en not_active Abandoned
- 1986-02-07 GR GR860365A patent/GR860365B/el unknown
- 1986-02-10 HU HU86531A patent/HUT40411A/hu unknown
- 1986-02-10 PT PT82006A patent/PT82006B/pt unknown
- 1986-02-10 NO NO860461A patent/NO860461L/no unknown
- 1986-02-10 EP EP86300886A patent/EP0194047A1/en not_active Withdrawn
- 1986-02-11 DK DK65586A patent/DK65586A/da not_active Application Discontinuation
- 1986-02-11 FI FI860617A patent/FI860617A/fi not_active Application Discontinuation
- 1986-02-11 ES ES551846A patent/ES8802029A1/es not_active Expired
- 1986-02-12 JP JP61028757A patent/JPS61233666A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NO860461L (no) | 1986-08-12 |
FI860617A0 (fi) | 1986-02-11 |
GR860365B (en) | 1986-06-03 |
GB8503427D0 (en) | 1985-03-13 |
EP0194047A1 (en) | 1986-09-10 |
HUT40411A (en) | 1986-12-28 |
PT82006B (en) | 1987-12-22 |
JPS61233666A (ja) | 1986-10-17 |
DK65586A (da) | 1986-08-12 |
IL77800A0 (en) | 1986-08-31 |
FI860617A (fi) | 1986-08-12 |
AU5326586A (en) | 1986-08-14 |
DK65586D0 (da) | 1986-02-11 |
IE860267L (en) | 1986-08-11 |
PT82006A (en) | 1986-03-01 |
ES8802029A1 (es) | 1988-03-16 |
ES551846A0 (es) | 1988-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8510758D0 (en) | Compounds | |
GB8501999D0 (en) | Compounds | |
GB8507942D0 (en) | Compounds | |
GB8505285D0 (en) | Compounds | |
GB8511988D0 (en) | Compounds | |
GB2178740B (en) | Alkylcarbamoyloxymethylcephem compounds | |
GB2203433B (en) | Trizinyl compounds | |
EP0199465A3 (en) | Cyanoalkanimidamido compounds | |
GB2169897B (en) | 5- halopyridine-3-carboxamide compounds | |
GB2170200B (en) | Acylaminoalkanoyl compounds | |
GB8510752D0 (en) | Compounds | |
GB2183236B (en) | Carbamoyloxymethylalkylcarbapenem compounds | |
GB8503358D0 (en) | Compounds | |
GB2175586B (en) | Mycotrienin-related compounds | |
PT82006A (en) | Basic compounds | |
GB8509834D0 (en) | Compounds | |
GB8511759D0 (en) | Compounds | |
GB8508972D0 (en) | Compounds | |
GB8512142D0 (en) | Compounds | |
GB8506642D0 (en) | Compounds | |
GB8502690D0 (en) | Compounds | |
GB8510331D0 (en) | Compounds | |
GB8510759D0 (en) | Compounds | |
GB8504682D0 (en) | Compounds | |
GB8504608D0 (en) | Compounds |